Articles related to BREAST SURGERY

Breast cancer surgical management requires ongoing patient education to address persistent misconceptions about treatment options and outcomes.

The recent FDA approval of Lumicell’s breast cancer imaging system introduces a novel intraoperative tool that significantly enhances the precision of tumor resections, potentially reducing the need for subsequent corrective surgeries.

With expert-led sessions encompassing a broad spectrum of breast disease management, from genetic risk assessment to cutting-edge oncological treatments, the course is a great opportunity to fortify your practice and enhance patient care.

The potential removal of the DIEP flap’s unique medical billing code by CMS could pose significant barriers to this beneficial breast reconstruction option, prompting calls for its preservation to ensure continued access and patient choice. Dive in to explore the implications of this pivotal issue for breast cancer patients and the health care system.

As we continue to improve the sensitivity of breast imaging, the need for surgical excision of benign proliferative lesions diagnosed on core needle biopsy remains a contentious topic, calling for careful examination of acceptable excision thresholds, patient preferences, and potential disparities in care.

The imminent CMS coding changes, leading to massive pay cuts, threaten to significantly reduce the availability of DIEP flap breast reconstruction, a procedure renowned for its superior patient outcomes. The potential repercussions, such as increased health disparities and a loss of specialized surgical skills, underscore the urgent need for policy reconsideration.